ISIS 3521

BIOLOGICAL3 trials

Sponsors

Eastern Cooperative Oncology Group, European Organisation for Research and Treatment of Cancer - EORTC, Ionis Pharmaceuticals, Inc.

Conditions

Breast CancerLung CancerMelanoma (Skin)

Phase 2

Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer

CompletedNCT00003236

Eastern Cooperative Oncology GroupBreast Cancer

Start: 1998-07-13Updated: 2023-06-18

ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma

CompletedNCT00003989

European Organisation for Research and Treatment of Cancer - EORTCLung Cancer, Melanoma (Skin)

Start: 1998-06-30Target: 50Updated: 2012-07-11

Phase 3

Carboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung Cancer

CompletedNCT00017407

Ionis Pharmaceuticals, Inc.Lung Cancer

Start: 2000-10-13End: 2002-09-09Updated: 2022-12-05